FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 337:494-496 August 14, 1997 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Reed–Sternberg cells and their variants have long held fascination for students of Hodgkin's disease. What are these cells, and how do they relate to the clinical manifestations of the lymphoma? Recent work indicates that they are clones of neoplastic B cells that, by secreting potent cytokines, not only cause the symptoms of Hodgkin's disease but also promote their own growth and evade immune surveillance.¹

The morphologically distinctive and multinucleated Reed–Sternberg cells — classic Reed–Sternberg cells — may derive from T cells in some cases, but the weight of the evidence suggests that they usually originate from B lymphocytes in germinal . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.